In 2025, landmark obesity drug deals, China’s biotech surge, and AI’s deeper integration into pharma operations drove a year ...
4don MSN
Forget Recursion Pharmaceuticals: This Could Be an Even Better Artificial Intelligence (AI) Stock
Recursion Pharmaceuticals ( RXRX 1.39%) has been a pioneer in using artificial intelligence (AI) to improve the drug ...
ESTERO, FL / ACCESS Newswire / November 6, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) (“Aspire” or the “Company”), ...
Axtria Inc., a global leader in AI-first data analytics solutions for the life sciences industry, today announced the launch ...
President Trump wants pharmaceutical production to return to the United States. A shuttered factory in Louisiana shows how ...
Several pharmaceutical companies have said they will sell drugs directly to patients in the US and offer discounts ...
The Swiss pharmaceutical giant's plant will produce compounds needed for radioligand therapy (RLT), a form of precision ...
Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company ...
5d
Mint Explainer | Why the drug regulator is cracking down on small and medium-sized pharma companies
India's drug regulator is tightening quality control measures, demanding compliance from MSME pharmaceutical manufacturers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback